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S U M M A R Y
Objectives: The aim of this study was to identify risk factors associated with severe scrub typhus, in order
to provide a reference for clinical decision-making.
Methods: A case–control study was conducted of scrub typhus patients who presented at local hospitals
between 2010 and 2013. In total, 46 patients with severe scrub typhus complications (cases) and
194 without severe complications (controls) were included.
Results: There were signiﬁcant differences in the duration of illness before effective antibiotic therapy,
lymphadenopathy, rash, blood platelet count, white blood cell (WBC) count, percentage neutrophils, and
percentage lymphocytes between the case and control groups. Multivariate analysis demonstrated that
the following four factors were signiﬁcantly associated with the severe complications of scrub typhus:
(1) duration of illness before effective antibiotic therapy (odds ratio (OR) 2.287, 95% conﬁdence interval
(CI) 1.096–4.770); (2) the presence of a rash (OR 3.694, 95% CI 1.300–10.495); (3) lymphadenopathy (OR
2.438, 95% CI 1.090–5.458); (4) blood platelet count <100  109/l (OR 2.226, 95% CI 1.002–4.946).
Conclusions: This study indicates that improved diagnosis and timely treatment are important factors for
the prevention of severe scrub typhus. When scrub typhus patients present with a rash, lymphadenopathy,
or blood platelet count <100  109/l, clinicians should be alert to the appearance of severe complications.
 2014 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/3.0/).
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jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j id1. Introduction
Scrub typhus, an acute febrile infectious disease caused by
Orientia tsutsugamushi, is widely endemic in the Asia Paciﬁc
regions, with an estimated one million cases annually.1 It is
transmitted to humans by the bite of an infected larval mite. Scrub
typhus is an infection that may lead to generalized vasculitis,
which may cause multiorgan dysfunction syndrome.2 In China,
scrub typhus was ﬁrst reported in Guangzhou in 1948, while the
ﬁrst outbreak occurred in Shandong in 1986.3,4 Previous studies
have revealed that the incidence of scrub typhus has increased year
on year in a nationwide region of China in recent years.4,5
According to the China information system for disease control and
prevention, there were 246, 452, 616, and 628 scrub typhus cases
in Shandong Province in the years 2010 to 2013, with one death
reported in 2010. Antibiotics of the tetracycline class are effective
in preventing fatal complications resulting from scrub typhus if* Corresponding author. Fax: +86 0531 88382128.
E-mail address: ztzhao@sdu.edu.cn (Z. Zhao).
http://dx.doi.org/10.1016/j.ijid.2014.09.019
1201-9712/ 2014 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).the disease is diagnosed in a timely manner. However, owing to the
fact that scrub typhus is a new emerging infectious disease in
northern China, the neglect of scrub typhus was unavoidable
in most epidemic regions. Cases of misdiagnosis were reported
quite frequently.6,7
Severe complications such as encephalitis, pneumonia, myo-
carditis, pericarditis, acute renal failure, acute hepatic failure, acute
hearing loss, and acute respiratory distress syndrome (ARDS) have
been reported in many cases.8–10 Some of these complications may
lead to death.11,12 As cases of death have been reported in recent
years, it would be of great value to clarify the factors related to
severe scrub typhus.13 However, few studies have been done in
China.5 Thus, we conducted this study to identify the predictors
of severe scrub typhus.
2. Materials and methods
2.1. Ethical statement
The study was conducted after obtaining the approval of the
Ethics Committee on Preventive Medicine of Shandong University.ciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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participants and from the legal guardians of juveniles.
2.2. Patients and data sources
Considering the incidences and case distribution in different
areas of Shandong, stratiﬁed cluster sampling was applied to select
the areas for investigation. Nine county-level districts were
selected randomly for this study (Xintai, Jimo, Jiaonan, Laicheng,
Gangcheng, Yiyuan, Yinan, Donggang, and Wendeng). Patients
with clinically suspected scrub typhus presenting to hospitals
were identiﬁed using the diagnostic criteria described below. A
structured questionnaire was used to record patient demographic
information, hematologic laboratory tests, clinical manifestations
and complications, and the outcome of the patients from January 1,
2010 to December 31, 2013. The information listed above was
reviewed retrospectively.
2.3. Case deﬁnition
Patients who had three or more of the following items could be
diagnosed as a case of scrub typhus: (1) a history of ﬁeld exposure
1–3 weeks before symptom onset, (2) symptoms including high
fever, lymphadenopathy, skin rash, splenomegaly, hepatomegaly,
or multiorgan dysfunction, (3) typical cutaneous lesions, such as
eschars or ulcers, (4) rapid defervescence with appropriate
antibiotics, and (5) Weil–Felix OX-K agglutination titer 1:80.
Patients were conﬁrmed by nested PCR test targeting the 56-kDa
gene of O. tsutsugamushi or by rapid immunochromatographic
immunoassay with a positive result for IgM or IgG.14
Scrub typhus patients with one or more of the following
manifestations were deﬁned as severe scrub typhus cases:
bronchopneumonia, meningoencephalitis, toxic hepatitis, acute
nephritis or renal failure, acute gastritis, gastrointestinal bleeding,
myocarditis, shock, and death. Controls in this study were scrub
typhus patients without the severe complications listed above.
2.4. Nested PCR
DNA was extracted from the patient blood samples, and coding
sequences targeting part of the 56-kDa gene of O. tsutsugamushi
were ampliﬁed using nested PCR. The following two sets of primers
were used in this study: outer primers, 34 (50-TCAAGCTTATTGC-
TAGTGCAATGTCTGC-30) and 55 (50-AGGGATCCCTGCTGCTGTGC
TTGCTGCG-30), and inner primers, 10 (50-GATCAAGCTTCCTCAGCC-
TACTATAATGCC-30) and 11 (50-CTAGGGATCCCGACAGATGCAC-
TATTAGGC-30).15 The expected length of the product was
481–507 bp.
The initial round of PCR was started with a 5 min denaturation
at 94 8C, followed by 30 cycles of 95 8C for 30 s, 57 8C for 2 min, and
70 8C for 2 min, and then a ﬁnal extension at 72 8C for 10 min.
Three microliters of the product was used as the template for the
second round of PCR, which used the same reaction conditions as
the initial one. The nested PCR products were visualized with an
ultraviolet transilluminator after agarose gel electrophoresis and
staining with ethidium bromide.
2.5. Statistical analysis
Epidata 3.1 was used to set up a database (Jens M. Lauritsen,
Odense, Syddanmark, Denmark), and the accuracy was ensured
with double data entry and logistic consistency checking. SPSS
version 16.0 software (SPSS Inc., Chicago, IL, USA) was used for the
statistical analysis. Continuous data were expressed as the mean 
standard deviation (SD), and the unpaired Student t-test was used to
compare the means between the two study groups. Categorical datawere expressed as the frequency or proportion, and the statistical
signiﬁcance of the difference in proportions between the two groups
was determined by Chi-square test or Fisher’s exact test. Two-sided
p-values of <0.05 were considered statistically signiﬁcant. The
associations between markers and severe scrub typhus were
determined by Chi-square test and univariate logistic regression
analysis. Input variables for the multivariate analysis were selected
from signiﬁcant variables derived from the univariate analysis.
Multivariate analysis was then performed with the independent
variables that were signiﬁcantly associated with severe scrub typhus
in the univariate analysis. The linearity of continuous variables, such
as age and days of duration of illness before effective antibiotic
therapy, were dichotomized with the mean as the cut-off point. Other
continuous laboratory variables, such as the platelet count, white
blood cell (WBC) count, percentage of neutrophils, percentage of
lymphocytes, aspartate aminotransferase (AST), alanine aminotrans-
ferase (ALT), total bilirubin, and direct bilirubin, were dichotomized
with the point at the normal range for the laboratory index. The odds
ratio (OR) with 95% conﬁdence intervals (95% CI) was presented to
examine statistical signiﬁcance.
3. Results
A total of 317 patients were recruited into this study, among
whom 240 met the criteria for scrub typhus infection and had
complete questionnaires. Severe scrub typhus such as broncho-
pneumonia, toxic hepatitis, acute gastritis, myocarditis, pleurisy,
meningoencephalitis, heart failure, and emphysema was observed
in 46 of the 240 patients (19.2%); these patients formed the case
group in this study. The remaining 194 patients without severe
scrub typhus formed the control group. Bronchopneumonia
and toxic hepatitis were the predominant complications, with
percentages of 41.3% and 21.7%, respectively.
Table 1 presents the main characteristics and laboratory
ﬁndings of the study patients. The mean age of the case group
was 57.33  17.69 years, and that of the control group was
53.35  19.13 years. No signiﬁcant difference was found in age,
gender, AST, ALT, total bilirubin, direct bilirubin, the presence of an
eschar, or fever between the two groups. However, there were
signiﬁcant differences in the duration from disease onset to
effective antibiotic therapy, the presence of a rash, lymphadenopathy,
platelet count, WBC count, percentage of neutrophils, and percentage
of lymphocytes between the two groups.
A univariate logistic regression model was ﬁtted to test for
signiﬁcant correlations between the above factors and severe scrub
typhus. Table 2 shows the signiﬁcant factors for severe scrub
typhus, which were as follows: (1) duration of illness before
effective antibiotic therapy, (2) lymphadenopathy, (3) the presence
of a rash, (4) platelet count <100  109/l, (5) percentage of
neutrophils <50%, (6) percentage of lymphocytes >40%, (7) total
bilirubin >0.024 mmol/l, and (8) direct bilirubin >0.009 mmol/l.
Multivariate unconditional logistic regression was applied to
estimate the association between the risk of severe scrub typhus
and the eight factors above. The results demonstrated that the
following four factors were signiﬁcantly associated with severe
scrub typhus: (1) duration of illness before effective antibiotic
therapy (OR 2.287, 95% CI 1.096–4.770, p = 0.027), (2) lymphade-
nopathy (OR 2.438, 95% CI 1.090–5.458, p = 0.030), (3) the presence
of a rash (OR 3.694, 95% CI 1.300–10.495, p = 0.014), and (4)
platelet count <100  109/l (OR 2.226, 95% CI 1.002–4.946,
p = 0.050). The results are detailed in Table 3.
4. Discussion
Scrub typhus was once considered a traditional tropical disease.
However, it has emerged in the temperate zone in northern China
Table 2
Unadjusted relative risks of each factor for severe scrub typhus
Factors Severe scrub typhus
(n = 46)
Non-severe scrub typhus
(n = 194)
p-Value OR 95% CI
Age, >54 years 27 (58.7%) 109 (56.5%) 0.785 1.095 0.570–2.102
Gender
Female 25 (54.3%) 90 (46.4%) 0.333 1.376 0.722–2.622
Male 21 (45.7%) 104 (53.6%) - 1.000 -
Time taken to diagnosis, days 12 (26.1%) 69 (35.6%) 0.671 1.275 0.415–3.991
Duration of illness before effective antibiotic therapy, >4.5 days 30 (65.2%) 85 (43.8%) 0.010 2.404 1.231–4.698
Lymphadenopathy 16 (34.78%) 39 (20.10%) 0.036 2.120 1.052–4.273
Rash 40 (87.0%) 127 (65.5%) 0.007 3.517 1.419–8.717
Eschar 37 (80.4%) 157 (80.9%) 0.939 0.969 0.430–2.182
Platelet count, <100  109/l 16 (34.8%) 34 (17.9%) 0.014 2.447 1.202–4.983
WBC count, >10  109/l 5 (10.9%) 33 (17.4%) 0.287 0.580 0.213–1.579
Percentage of neutrophils
50–70a 22 (47.8%) 67 (35.4%) - 1.000 -
49.99 15 (32.6%) 97 (51.3%) 0.042 0.471 0.228–0.974
70.01 9 (19.6%) 25 (13.2%) 0.841 1.047 0.667–1.643
Percentage of lymphocytes
20–40a 26 (56.5%) 78 (41.3%) - 1.000 -
<20 9 (19.60%) 25 (13.2%) 0.864 1.080 0.447–2.608
>40 11 (23.9%) 86 (45.5%) 0.015 0.619 0.422–0.910
AST, >37 IU/l 38 (82.6%) 132 (75.9%) 0.334 1.511 0.654–3.493
ALT, >40 IU/l 35 (76.1%) 130 (74.7%) 0.848 1.077 0.504–2.300
Total bilirubin, >0.024 mmol/l 4 (8.7%) 4 (2.1%) 0.043 4.357 1.047–18.133
Direct bilirubin, >0.009 mmol/l 6 (13.0%) 7 (3.7%) 0.021 3.857 1.230–12.096
OR, odds ratio; CI, conﬁdence interval; WBC, white blood cell; AST, aspartate aminotransferase; ALT, alanine aminotransferase.
a Normal range for neutrophils 50–70%; normal range for lymphocytes 20–40%.
Table 1
Demographic and clinical characteristics of the study subjects
Subject characteristics Cases (n = 46) Controls (n = 194)
Mean SD n % Mean SD n %
Age, years 57.33 17.69 53.35 19.13
Gender
Female 25 90 46.39
Male 21 104 53.61
Time taken to diagnosis, days 1.33 1.86 2.43 3.43
Duration of illness before effective antibiotic therapy, daysa 6.17 4.74 4.15 3.67
Fever 46 100.00 194 100.00
Lymphadenopathya 16 34.78 39 20.10
Rasha 40 86.78 127 65.46
Eschar 37 80.43 157 80.93
Platelet count, cells 109/la 130.45 62.49 159.26 67.72
WBC count, cells 109/la 6.36 2.39 7.07 2.98
Neutrophil count, %a 54.18 19.04 48.95 18.81
Lymphocyte count, %a 32.38 15.30 39.88 17.96
AST, IU/l 74.19 49.81 83.58 95.72
ALT, IU/l 93.50 80.72 93.72 96.53
Total bilirubin, mmol/l 0.012 0.008 0.011 0.005
Direct bilirubin, mmol/l 0.005 0.006 0.004 0.002
SD, standard deviation; WBC, white blood cell; AST, aspartate aminotransferase; ALT, alanine aminotransferase.
a There was a signiﬁcant difference between the two groups (p < 0.05).
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over the past two decades. Since scrub typhus is not one of the
notiﬁable infectious diseases in mainland China, it is widely
neglected by both physicians and residents in epidemic foci.
Scrub typhus is usually contracted in rural areas, where most of
the residents are farmers. Poor sanitary conditions and long-time
exposure in the ﬁeld increase the chances of a farmer being bitten
by chigger mites harboring O. tsutsugamushi. The ﬁrst place a
farmer will seek medical help is usually the village clinic or a
township hospital. According to our investigation, the average
number of days before the patients received effective antibiotic
therapy was 4.5 days. There are at least two reasons for this delay:
ﬁrst, the patients themselves may not have been aware that the
disease may lead to severe complications without prompt
treatment, and second, the neglect of scrub typhus and delayeddiagnosis may have contributed to the misdiagnosis of scrub
typhus.6 The mean value for the duration of illness before effective
antibiotic therapy was 6.17 days in the case group and 4.15 days
in control group, and the difference was signiﬁcant. This result
indicates that, on average, patients in the case group received
effective treatment after the onset of scrub typhus 2 days later than
patients in the control group. Jang et al. also found that delays in
diagnosis and treatment were associated with complications and
mortality in scrub typhus patients.16
In recent years, a few studies on severe complications and the
mortality rate of scrub typhus have been published in some
countries.17,18 Kim et al. reported that age 60 years was an
independent predictive variable for the occurrence of severe scrub
typhus.17 In our study, the mean age of the patients was 54 years,
and multivariate logistic analysis indicated that age was not an
Table 3
Multivariate logistic regression analysis of risk factors for severe scrub typhusa
Factors p-Value OR 95% CI
Duration of illness before effective
antibiotic therapy, >4.5 days
0.027 2.287 1.096–4.770
Rash 0.014 3.694 1.300–10.495
Lymphadenopathy 0.030 2.438 1.090–5.458
Platelet count, <100  109/l 0.050 2.226 1.002–4.946
Total bilirubin, >24 mmol/l 0.382 2.733 0.286–26.096
Direct bilirubin, >8.6 mmol/l 0.514 1.768 0.319–9.818
Percentage of neutrophils
49.99 0.766 0.854 0.301–2.422
70.01 0.632 1.344 0.402–4.492
Percentage of lymphocytes
<20 0.791 1.176 0.355–3.891
>40 0.164 0.456 0.151–1.379
OR, odds ratio; CI, conﬁdence interval.
a Only the signiﬁcant risk factors in Table 2 were selected for this analysis.
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typhus; this is in contrast to the result of Kim et al. Further studies
are needed to conﬁrm the relationship between age and the
occurrence rate of severe scrub typhus.
Some studies have not analyzed lymphadenopathy. However,
in our study, scrub typhus patients with lymphadenopathy
(55 patients in total) appeared to have a 2.438 times higher risk
of severe scrub typhus than patients without lymphadenopathy
(85 patients in total). Scrub typhus has no speciﬁc clinical
presentations, which makes it hard to identify. In epidemic
regions, most of which are rural areas in Shandong Province,
lymphadenopathy together with fever, eschar (or skin ulcer), and a
skin rash are the indications of scrub typhus for the experienced
clinician. According to our multivariate logistic analysis, it is also
an independent risk factor for severe scrub typhus. Scrub typhus
patients with lymphadenopathy should be taken good care of, in
case severe complications occur.
As well as the duration of illness before effective antibiotic
therapy and lymphadenopathy, two other factors were found to be
independently predictive of the occurrence of severe scrub typhus
by multivariate analysis in our study. These were the presence of a
rash and a platelet count <100  109/l. According to various
reports, the occurrence of skin rash as well as eschar has been
shown to differ among epidemic regions.2,18,19 The occurrence rate
of skin rash has been reported to be as high as 93% in the study by
Ogawa et al. in Japan,2 and also as low as 22% in the study by
Mathai et al. in South India.19 However, in our study we found that
87.0%, 65.5%, and 69.6% of severe scrub typhus patients, non-severe
scrub typhus patients, and all 240 patients, respectively, had a rash.
In contrast to our study, Kim et al. reported that skin rash was not a
relative risk for severe scrub typhus, while the absence of an eschar
was a relative risk.17 These differences could be attributed to the
local prevalent genotypes of O.tsutsugamushi.20 Similar to lymph-
adenopathy, if a scrub typhus patient develops a rash, the clinician
should be aware of the possible complications and intensive
care should be given to the patient.
Univariate analysis showed that the platelet count in the severe
scrub typhus group was signiﬁcantly lower than in the non-severe
scrub typhus group (platelet count <100  109/l: 34.8% in the case
group and 17.9% in the control group, p < 0.05), with a similar WBC
count. Tsay and Chang21 and Mathai et al.19 reported thrombocy-
topenia in severe scrub typhus patients. However, Mathai et al.
found that when the combination of elevated transaminases,
thrombocytopenia, and leukocytosis was used, their speciﬁcity and
positive predictive value were around 80%, but thrombocytopenia
itself was not sensitive enough to predict scrub typhus.19 The
present study and that by Su et al., identiﬁed thrombocytopenia as
being associated with severe complications.22 Thrombocytopenialeads to problems with coagulation, and has been identiﬁed as a
risk factor for the development of ARDS, which is a rarely reported
but serious complication that may lead to death.23 Therefore,
thrombocytopenia is a plausible risk factor for severe scrub
typhus.9
There are several limitations to this study. First, the patient
clinical information was retrieved retrospectively. Thus, clinical
information is not integrated to some degree. A few values such as
the amount of albumin and creatinine were not assessed.17,18
Second, we performed this study in Shandong Province, where the
main genotype of O. tsutsugamushi is Kawasaki-related; the
application of our results to other epidemic areas with different
genotypes could therefore be limited. Third, selection bias is
unavoidable with a hospital-based design. Nevertheless, our
results could be representative of Shandong and some other
epidemic regions that share the same genotype, and they provide
reference information for other epidemic areas. As well as the
duration of illness before effective antibiotic therapy, the other
three parameters reported in this study could be checked in most
medical institutions, even in township hospitals.
In summary, health education should be carried out in epidemic
zones to raise the residents’ awareness of this disease, so that they
attend hospital as soon as they feel sick. Further, better physician
awareness and improved diagnosis could effectively speed
diagnosis. Once a scrub typhus patient presents a skin rash,
lymphadenopathy, platelet count <100  10 9/l, or thrombocyto-
penia, the clinician should be aware of the possibility of severe
complications. Close observation should be applied to these
patients to prevent severe complications and mortality.
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